
CareDx
Innovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey.
Enterprise value
$870m
Share price
$19.54 CDNA
Recent deals
Authorizing premium user...
Innovative noninvasive testing solutions enhancing transplant patient outcomes throughout their journey.